Efficacy of Mobile Phone Technology for Managing Side Effects Associated with Chemotherapy among Cancer Patients: A Systematic Review and Meta-Analysis

Abstract

Background To establish the evidence related to the efficacy of mobile phone technology for managing side effects of chemotherapy and improved quality of life among patients with cancer.

Methods Articles published in peer-reviewed journals were included in this review. Randomized control trials (RCTs) and non-randomized control trials (non-RCTs) consisting of mobile-based interventions (mobile application, smart phone App-based interventions or guidelines to manage side-effects of chemotherapy or mobile health services), and adult cancer patients (aged 18 or above years) as participants who were undergoing chemotherapy and received mobile phone-based interventions as an interventional group versus control/comparator group who were getting routine or usual care were included in this systematic review. Databases such as Scopus, Science Direct, Cochrane library, PubMed, and Google Scholar were systematically searched between 2007 and 2020. Using the Cochrane risk of bias tool, the methodological quality of the included studies was evaluated by two independent authors.

Results We included 10 trials, involving 1467 cancer patients and the number of participants ranged from 50 to 457. All trials measured the side effects of chemotherapy as the main outcome and three trials measured the quality of life as the main outcome.

Ten trials included for narrative synthesis showed a significant decrease in chemotherapy side effects and considerable improvement in the quality of life in the interventional group than in the comparison group. Meta-analysis of four RCTs containing 803 subjects concluded a significant improvement (p < 0.0001) in the quality of life.

A significant improvement in the quality of life was revealed by random effects model (SMD = 0.31, 95% CI: 0.17, −0.46) and a significant difference (Z = 4.37, p < 0.001) was identified between experimental and control groups.

Conclusion Current review strengthens the evidence that utilizing mobile-phone based technology has favorable effects on improving the quality of life by minimizing side-effects associated with chemotherapy among cancer patients.

Keywords

chemotherapy - side-effects - mobile apps/smartphone applications - cancer patient

Systematic Review Registration No

International Prospective Register for Systematic Reviews (Prospero Registration No-CRD42020152520).

Publikationsverlauf

Artikel online veröffentlicht:
11. Dezember 2021

• References

• 1 Uddin J, Biswas T, Adhikary G. et al. Impact of mobile phone-based technology to improve health, population and nutrition services in rural Bangladesh: a study protocol. BMC Med Inform Decis Mak 2017; 17 (01) 101
• 2 Akter S, Ray P. mHealth - an Ultimate Platform to Serve the Unserved. Yearb Med Inform 2010; 94-100
• 3 Cancer [Internet]. [Cited 2021 Jan 21]. Accessed October 18, 2021 from: https://www.who.int/news-room/fact-sheets/detail/cancer
• 4 Treatment Modalities of Cancer | Cancer Treatment Methods - Cytecare [Internet]. Cytecare Hospital in Bangalore. 2019 [cited 2021 Jan 21]. Available from: https://cytecare.com/blog/treatment-modalities-of-cancer/
• 5 Chan H-K, Ismail S. Side effects of chemotherapy among cancer patients in a Malaysian General Hospital: experiences, perceptions and informational needs from clinical pharmacists. Asian Pac J Cancer Prev 2014; 15 (13) 5305-5309
• 6 Pearce A, Haas M, Viney R. et al. Incidence and severity of self-reported chemotherapy side effects in routine care: a prospective cohort study. Ganti AK, editor. PLoS One 2017; 12 (10) e0184360 . Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634543/. Accessed November 22, 2021
• 7 Weaver A, Young AM, Rowntree J. et al. Application of mobile phone technology for managing chemotherapy-associated side-effects. Ann Oncol 2007; 18 (11) 1887-1892
• 8 Brant JM, Beck SL, Dudley WN, Cobb P, Pepper G, Miaskowski C. Symptom trajectories during chemotherapy in outpatients with lung cancer colorectal cancer, or lymphoma. Eur J Oncol Nurs 2011; 15 (05) 470-477
• 9 Davoodi S, Safdari R, Ghazisaeidi M, Mohammadzadeh Z, Azadmanjir Z. Prevention and early detection of occupational cancers - a view of information technology solutions. Asian Pac J Cancer Prev 2015; 16 (14) 5607-5611
• 10 Agboola S, Flanagan C, Searl M, Elfiky A, Kvedar J, Jethwani K. Improving outcomes in cancer patients on oral anti-cancer medications using a novel mobile phone-based intervention: study design of a randomized controlled trial. JMIR Res Protoc 2014; 3 (04) e79
• 11 Rico TM, Dos Santos Machado K, Fernandes VP. et al. Use of text messaging (SMS) for the management of side effects in cancer patients undergoing chemotherapy treatment: a randomized controlled trial. J Med Syst 2020; 44 (11) 193
• 12 Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353 (05) 487-497
• 13 Egbring M, Far E, Roos M. et al. A mobile app to stabilize daily functional activity of breast cancer patients in collaboration with the physician: a randomized controlled clinical trial. J Med Internet Res 2016; 18 (09) e238
• 14 Richards R, Kinnersley P, Brain K, McCutchan G, Staffurth J, Wood F. Use of mobile devices to help cancer patients meet their information needs in non-inpatient settings: systematic review. JMIR Mhealth Uhealth 2018; 6 (12) e10026
• 15 Crafoord M-T, Fjell M, Sundberg K, Nilsson M, Langius-Eklöf A. Engagement in an interactive App for symptom self-management during treatment in patients with breast or prostate cancer: mixed methods study. J Med Internet Res 2020; 22 (08) e17058
• 16 Aromataris E, Munn Z. Joanna Briggs Institute Manual for Evidence synthesis. JBI; 2020
• 17 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6 (07) e1000097
• 18 Guyatt GH, Thorlund K, Oxman AD. et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol 2013; 66 (02) 173-183
• 19 GRADEpro GDT. GRADEpro Guideline Development Tool [Software]. McMaster University; 2015 (developed by Evidence Prime, Inc.). Available from gradepro.org
• 20 Alboughobeish SZ, Asadizaker M, Rokhafrooz D, Cheraghian B. The effect of mobile-based patient education on nausea and vomiting of patients undergoing chemotherapy. Biomed Res 2017;28(19)
• 21 Basch E, Deal AM, Kris MG. et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 2016; 34 (06) 557-565
• 22 Di R, Li G. Use of a smartphone medical app improves complications and quality of life in patients with nasopharyngeal carcinoma who underwent radiotherapy and chemotherapy. Med Sci Monit 2018; 24: 6151-6156
• 23 Greer JA, Jacobs JM, Pensak N. et al. Randomized trial of a smartphone mobile app to improve symptoms and adherence to oral therapy for cancer. J Natl Compr Canc Netw 2020; 18 (02) 133-141
• 24 Handa S, Okuyama H, Yamamoto H, Nakamura S, Kato Y. Effectiveness of a smartphone application as a support tool for patients undergoing breast cancer chemotherapy: a randomized controlled trial. Clin Breast Cancer 2020; 20 (03) 201-208
• 25 Hou IC, Lin HY, Shen SH. et al. Quality of life of women after a first diagnosis of breast cancer using a self-management support mHealth App in Taiwan: randomized controlled trial. JMIR Mhealth Uhealth 2020; 8 (03) e17084
• 26 Kearney N, McCann L, Norrie J. et al. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer 2009; 17 (04) 437-444
• 27 Kim HJ, Kim SM, Shin H, Jang J-S, Kim YI, Han DH. A mobile game for patients with breast cancer for chemotherapy self-management and quality-of-life improvement: randomized controlled trial. J Med Internet Res 2018; 20 (10) e273